- cafead Sep 30, 2020 at 11:02: PM
via The pharmaceutical industry has constantly come under fire over such issues as high drug prices and patent evergreening. But as COVID-19 rages across the globe, accentuating the need for therapeutics and vaccines, drugmakers should embrace the chance to change the public’s perception.
That’s the message GlaxoSmithKline CEO Emma Walmsley conveyed at the third annual Helen Alexander Memorial Lecture. But the rare opportunity at redemption also comes with a challenge, she warned.
article source
That’s the message GlaxoSmithKline CEO Emma Walmsley conveyed at the third annual Helen Alexander Memorial Lecture. But the rare opportunity at redemption also comes with a challenge, she warned.
article source